New Era for Renal-Protective Therapy in Type 2 Diabetes: Better Renal Outcomes in Patients with Type 2 Diabetes Taking Sodium-Glucose Cotransporter 2 Inhibitors versus Dipeptidyl Peptidase-4 Inhibitors

Detalles Bibliográficos
Autor principal: Jung, Chan-Hee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Endocrine Society 2021
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090473/
https://www.ncbi.nlm.nih.gov/pubmed/33934589
http://dx.doi.org/10.3803/EnM.2021.203

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090473/
https://www.ncbi.nlm.nih.gov/pubmed/33934589
http://dx.doi.org/10.3803/EnM.2021.203

Ejemplares similares